Manual Construction of a Tissue Microarray using the Tape Method and a Handheld Microarrayer
June 10th, 2022
16K views
This protocol outlines the tape method on how to manually construct a tissue microarray using FFPE donor blocks of differing depths.
Overview
This protocol outlines the tape method for manually constructing a tissue microarray (TMA) using FFPE donor blocks of varying depths. The process involves careful core sampling and mapping to ensure accurate representation of tissue structures.
Key Study Components
Area of Science
- Neuroscience
- Pathology
- Tissue Engineering
Background
- The tissue microarray (TMA) is a crucial tool for research, allowing for the analysis of multiple tissue samples simultaneously.
- Formalin-fixed paraffin embedded (FFPE) blocks contain three-dimensional tissue structures that require careful consideration during sampling.
- Pathologists play a vital role in identifying areas of interest within the tissue blocks for core sampling.
- The tape method offers a manual, cost-effective approach to TMA construction.
Purpose of Study
- To demonstrate the tape method for constructing TMAs from FFPE donor blocks.
- To highlight the importance of accurate core sampling in preserving tissue integrity.
- To provide a visual understanding of the three-dimensional nature of tissue within FFPE blocks.
Methods Used
- Pathologist review and marking of tissue sections for core sampling.
- Creation of TMA and construction maps to guide core placement.
- Use of a disposable paper checkered grid for accurate core positioning.
- Manual core punching and embedding of cores in paraffin.
Main Results
- The tape method allows for effective construction of TMAs from non-ideal donor blocks.
- Accurate mapping ensures that cores are placed correctly to represent the tissue structure.
- Visual aids, such as animations, enhance understanding of tissue sampling challenges.
- Proper technique minimizes the risk of sampling errors and improves research outcomes.
Conclusions
- The tape method is a reliable and accessible technique for TMA construction.
- Collaboration between pathologists and researchers is essential for successful tissue sampling.
- Understanding the three-dimensional nature of tissue is critical for accurate analysis.
Frequently Asked Questions
What is a tissue microarray?
A tissue microarray (TMA) is a technique that allows researchers to analyze multiple tissue samples simultaneously by embedding small cores from various donor blocks into a single paraffin block.
Why is the tape method used?
The tape method is used for its cost-effectiveness and compatibility with non-ideal donor blocks, allowing for manual construction of TMAs.
How does the three-dimensional nature of tissue affect sampling?
The three-dimensional nature means that the tissue composition can vary at different depths, making careful sampling essential to avoid areas of necrosis or non-representative tissue.
What role do pathologists play in TMA construction?
Pathologists review tissue blocks, mark areas of interest, and guide the core sampling process to ensure that relevant tissue is included in the TMA.
What is the importance of the TMA map?
The TMA map outlines the locations of the cores in the completed TMA, ensuring accurate representation of the sampled tissues.
How is the construction map different from the TMA map?
The construction map is a mirror image of the TMA map, showing where each core must be placed during construction to appear correctly in the final TMA.
Executive Industry Relevance
Tissue microarray construction enables high-throughput analysis of protein expression and genomic alterations across numerous formalin-fixed paraffin embedded samples, reducing tissue consumption and reagent costs in discovery workflows. The tape method provides a low-cost, manual approach compatible with non-ideal donor blocks, supporting early-stage target validation where sample availability is limited. This facilitates mechanistic de-risking by allowing parallel assessment of therapeutic hypotheses across diverse tissue contexts.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by assessing protein expression and transcriptional alterations across multiple donor blocks simultaneously.
- Operational Value: Supports biological de-risking through parallel evaluation of target presence in diverse tissue samples, aiding portfolio triage decisions.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for downstream immunohistochemistry and RNA ISH assays, ensuring reliable compound evaluation.
- Operational Value: Standardizes tissue sampling through pathologist-guided core placement, improving reproducibility across screening campaigns.
Translational & Preclinical Research
- Scientific Value: Maintains disease relevance by preserving tissue architecture from donor blocks, enabling translational biomarker alignment.
- Operational Value: Provides continuity from discovery through preclinical validation by allowing consistent tissue sectioning for longitudinal analysis.
Pipeline & Workflow Integration
The tape method supports early discovery workflows by enabling hypothesis testing through multiplexed tissue analysis, positioning it prior to lead identification and preclinical validation stages.
- Discovery Biology: Supports pathway clarification and biological de-risking by allowing assessment of target expression across heterogeneous tissue samples.
- Screening: Enables assay readiness through standardized core placement and quantitative output generation for immunohistochemical and RNA ISH readouts.
- Analytics: Generates multiplexed protein and transcriptional readouts that help compare conditions across donor blocks.
- Translational Research: Connects discovery to preclinical continuity by preserving tissue context for biomarker validation.
- Enterprise Reuse: Establishes a reusable capability for multi-project target validation rather than a single-use technique.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence through multiplexed assessment of target presence, reducing mechanistic ambiguity in early discovery.
- Operational Value: Standardization and reproducibility via pathologist-reviewed core sampling and mapping procedures.
- Strategic Value: Better go/no-go decisions through risk-adjusted prioritization of targets based on multi-sample tissue profiling.
- Portfolio Impact: Enables capital-efficient advancement decisions by identifying targets with consistent expression across diverse tissue contexts.
Implementation Considerations
- Required scientific expertise in histopathology for tissue review and core sampling guidance.
- Instrumentation needs include handheld core punches, microtomes, and paraffin embedding equipment.
- Cross-team standardization requires alignment between pathology and research teams on tissue marking and mapping protocols.
- Adaptation considerations across model systems depend on FFPE tissue availability and core length compatibility.
- Practical limitations include core loss during sectioning and variability in tissue representation due to block heterogeneity.
Biopharma FAQs
Why does pathological review matter for target validation in TMA construction?
Pathological review ensures that tissue cores are sampled from regions of interest while excluding necrosis or non-representative areas, which is critical for accurate target validation. This step prevents false-negative or misleading results in downstream immunohistochemical and RNA ISH analyses by confirming that the sampled tissue reflects the intended biological context.
How does independent variable isolation fit the discovery pipeline in TMA workflows?
Isolating independent variables such as tissue core placement and orientation through TMA and construction maps ensures that observed differences in protein expression or genomic alterations are attributable to biological variables rather than technical artifacts. This supports reliable hypothesis testing in early discovery by maintaining assay consistency across samples.
What quantitative dependent variable measurements enable target assessment in TMA studies?
Quantitative measurements include immunohistochemical staining intensity, RNA ISH signal density, and chromogenic or fluorescent readouts that enable objective comparison of target expression levels across tissue cores. These measurements support data-driven decisions in target validation and lead identification by providing comparable, multiplexed outputs.
Why do replication requirements matter for cross-functional collaboration in TMA generation?
Replication requirements ensure that TMA construction is reproducible across different operators and batches, which is essential for cross-functional teams to compare results confidently. Standardized procedures such as pathologist-guided marking and map-based core placement reduce variability and support reliable data sharing between discovery and translational teams.
What statistical analysis capabilities are required before implementing TMA data in target validation?
Before implementation, teams require capabilities to analyze multiplexed expression data across hundreds of tissue cores, including normalization for sectioning variability and statistical testing for significant differences in target presence. These capabilities enable robust evaluation of therapeutic hypotheses and support go/no-go decisions based on reproducible, quantitative tissue profiling.
